- Coordinator
- University of Galway, Ireland
- Runs
- 1 June 2023 to 31 May 2027
- Status
- Running
- EU funding
- €7.9m
- Total cost
- €7.9m
- Partners
- 42 organisations in 13 countries
- Type
- Research and Innovation Action
- Grant agreement
- 101080997
What the project is doing
In the project's own words, from its summary on CORDIS.
Our overall objectives are to accelerate the diagnosis, and enable personalised management, of inherited metabolic diseases (IMDs). Established academic technology for statistical genomic analysis, deep learning-based prediction of protein structure, and whole-body metabolic network modelling shall be applied to generate personalised computational models, given patient-derived genomic, transcriptomic, proteomic and metabolomic data.
To train diagnostic models, a comprehensive clinical team will recruit 1,945 diagnosed patients with a wide variety of IMDs, then validate the clinical utility of personalised computational models on a set of 685 undiagnosed patients. An enhanced human metabolic network reconstruction, especially for lipid metabolism, reaction kinetics and inherited metabolic disease pathways, will increase the predictive capacity of cellular and whole-body metabolic network models.
As an exemplar for other IMDs, personalised computational modelling will be used to identify compensatory and aggravating mechanisms that associate with clinical severity in Gaucher disease. The predictive capacity of personalised models will be validated by comparison with additional empirical investigations of protein structure and function as well as metabolomics, tracer-based metabolomics and proteomics of patient-derived in vitro disease models.
To maximise the potential for impact, personalised modelling software will be developed to be generally applicable to a broad variety of IMDs, and implemented in a way that is both accessible to clinicians and admissible to regulatory authorities. Sustainability will be promoted by development of a roadmap for a European foundation to aid personalised diagnosis and management of IMDs, informed by broad stakeholder consultation.
This is a unique opportunity to realise the potential of personalised computational modelling for a broad set of rare diseases, which is a field where European collaboration is an essential for progress.
Topics
Who is involved
| Organisation | City | Country | Role |
|---|---|---|---|
| University of Galway | Galway | Ireland | Coordinator |
| Medizinische Universitaet Wien | Wien | Austria | Participant |
| Katholieke Universiteit Leuven | Leuven | Belgium | Participant |
| Universitair Ziekenhuis Antwerpen | Edegem | Belgium | Participant |
| Sib Swiss Institute of Bioinformatics | Genf | Switzerland | Associatedpartner |
| Vseobecna Fakultni Nemocnice V Praze | Praha 2 | Czechia | Participant |
| Eberhard Karls Universitaet Tuebingen | Tuebingen | Germany | Participant |
| Klinikum Der Ludwig-Maximilians-Universitat Munchen | Munchen | Germany | Third party |
| Klinikum Der Technischen Universität München (tum Klinikum) | Muenchen | Germany | Participant |
| Ludwig-Maximilians-Universitaet Muenchen | Planegg | Germany | Participant |
| Medizinische Hochschule Hannover | Hannover | Germany | Participant |
| Universitaet Osnabrueck | Osnabrueck | Germany | Participant |
| Universitaetsklinikum Freiburg | Freiburg | Germany | Participant |
| Universitaetsklinikum Tuebingen | Tuebingen | Germany | Third party |
| Universitaetsmedizin Der Johannes Gutenberg-Universitaet Mainz | Mainz | Germany | Participant |
| Universitatsklinikum Heidelberg | Heidelberg | Germany | Participant |
| Region Hovedstaden | Hillerod | Denmark | Participant |
| Asociacion Instituto De Investigacion Sanitaria Biobizkaia | Barakaldo Bizkaia | Spain | Participant |
| Fundacion Para La Investigacion Biomedica Del Hospital Universitario 12 De Octubre | Madrid | Spain | Participant |
| Fundacion Publica Galega Instituto De Investigacion Sanitaria De Santiago De Compostela | Santiago De Compostela | Spain | Participant |
| Servicio Vasco de Salud Osakidetza | Vitoria-Gasteiz | Spain | Third party |
| Children's Health Ireland | Dublin | Ireland | Participant |
| Dundalk Institute of Technology | Dundalk | Ireland | Participant |
| Mater Misericordiae University Hospital | Dublin | Ireland | Participant |
| Azienda Ospedaliera Universitaria Meyer Irccs | Firenze | Italy | Participant |
| Azienda Sanitaria Universitaria Friuli Centrale | Udine | Italy | Participant |
| Fondazione Irccs Istituto Neurologico Carlo Besta | Milano | Italy | Participant |
| Ospedale Pediatrico Bambino Gesu | Roma | Italy | Participant |
| Uniamo - Federazione Italiana Malattie Rare - Onlus Associazione | Roma | Italy | Participant |
| Academisch Ziekenhuis Groningen | Groningen | Netherlands | Participant |
| Academisch Ziekenhuis Maastricht | Maastricht | Netherlands | Third party |
| Erasmus Universitair Medisch Centrum Rotterdam | Rotterdam | Netherlands | Participant |
| Stichting Amsterdam Umc | Amsterdam | Netherlands | Participant |
| Universitair Medisch Centrum Utrecht | Utrecht | Netherlands | Participant |
| Universiteit Leiden | Leiden | Netherlands | Participant |
| Universiteit Maastricht | Maastricht | Netherlands | Participant |
| Oslo Universitetssykehus Hf | Oslo | Norway | Participant |
| Vastra Gotalandsregionen | Vanersborg | Sweden | Participant |
| Belfast Health and Social Care Trust | Belfast | United Kingdom | Associatedpartner |
| The Chancellor, Masters and Scholars of the University of Oxford | Oxford | United Kingdom | Associatedpartner |
| University College London | London | United Kingdom | Associatedpartner |
| University of Newcastle Upon Tyne | Newcastle Upon Tyne | United Kingdom | Associatedpartner |
Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI